Q32 Bio (QTTB) Operating Margin Growth (1y) (2019 - 2023)
Q32 Bio (QTTB) Operating Margin Growth (1y) (2019 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
-1.03 Mn |
| Sep 30, 2023 |
367,803.00 |
| Jun 30, 2023 |
330,256.00 |
| Mar 31, 2023 |
444,034.00 |
| Dec 31, 2022 |
694,177.00 |
| Sep 30, 2022 |
-226,918.00 |
| Jun 30, 2022 |
-213,257.00 |
| Mar 31, 2022 |
-468,673.00 |
| Dec 31, 2021 |
830,449.00 |
| Sep 30, 2021 |
315,810.00 |
| Jun 30, 2021 |
489,879.00 |
| Mar 31, 2021 |
620,233.00 |
| Dec 31, 2020 |
149,877.00 |
| Sep 30, 2020 |
210,836.00 |
| Jun 30, 2020 |
84,020.00 |
| Mar 31, 2020 |
309,869.00 |
| Dec 31, 2019 |
-285,316.00 |
| Sep 30, 2019 |
-611,882.00 |
| Jun 30, 2019 |
-617,382.00 |
| Mar 31, 2019 |
-835,743.00 |
